-
公开(公告)号:EP3119782A1
公开(公告)日:2017-01-25
申请号:EP15710486.0
申请日:2015-03-17
申请人: reMYND NV
发明人: GRIFFIOEN, Gerard , DE TAEYE, Bart , PRINCEN, Katrien , DE WITTE, Koen , BLANCHE, Emilie , RATNI, Hasane , ROGERS-EVANS, Mark
IPC分类号: C07D471/10 , A61P3/10 , A61K31/438
CPC分类号: A61K31/5377 , A61K31/435 , A61K31/444 , C07D471/10
摘要: The present invention relates to a compound of formula (I) or a stereoisomer, enantiomer, racemic, or tautomer thereof, Formula (I), wherein R1, R3, R4, L1, L2, L3, L4, and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.
摘要翻译: 本发明涉及式(I)化合物或式(I)的立体异构体,对映异构体,外消旋或互变异构体,其中R1,R3,R4,L1,L2,L3,L4和n具有相同的 意义如权利要求和说明书中所限定的那样。 本发明还涉及包含这些化合物的组合物,特别是药物,以及这些化合物和组合物用于预防和/或治疗代谢紊乱和/或神经变性疾病和/或蛋白质错误折叠障碍的用途。
-
公开(公告)号:EP3119774A1
公开(公告)日:2017-01-25
申请号:EP15711117.0
申请日:2015-03-17
申请人: reMYND NV
发明人: GRIFFIOEN, Gerard , DE TAEYE, Bart , PRINCEN, Katrien , DE WITTE, Koen , BLANCHE, Emilie , RATNI, Hasane , NETTEKOVEN, Matthias , ROGERS-EVANS, Mark
IPC分类号: C07D413/14 , C07D413/04 , C07D413/06 , C07D413/12 , C07D271/07 , A61K31/496 , A61K31/438 , A61P25/00 , A61P3/00 , A61P9/00
CPC分类号: C07D271/07 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07D471/10
摘要: The present invention relates to a compound of formula (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein R
1 ,R
2 ,R
3 ,L
1 ,L
2 ,L
3 ,L
4 ,L
5 and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.摘要翻译: 本发明涉及式(I)或(II)化合物或其立体异构体,对映体,外消旋或互变异构体,(I)(II)其中R1,R2,R3,L1,L2,L3,L4,L5 和n具有与权利要求和说明书中所定义的相同的含义。 本发明还涉及包含这些化合物的组合物,特别是药物,以及这些化合物和组合物用于预防和/或治疗代谢紊乱和/或神经变性疾病和/或蛋白质错误折叠障碍的用途。
-
公开(公告)号:EP3119782B1
公开(公告)日:2018-01-31
申请号:EP15710486.0
申请日:2015-03-17
申请人: reMYND NV
发明人: GRIFFIOEN, Gerard , DE TAEYE, Bart , PRINCEN, Katrien , DE WITTE, Koen , BLANCHE, Emilie , RATNI, Hasane , ROGERS-EVANS, Mark
IPC分类号: C07D471/10 , A61P3/10 , A61K31/438
CPC分类号: A61K31/5377 , A61K31/435 , A61K31/444 , C07D471/10
摘要: The present invention relates to a compound of formula (I) or a stereoisomer, enantiomer, racemic, or tautomer thereof, Formula (I), wherein R1, R3, R4, L1, L2, L3, L4, and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.
-
-